Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1995European Journal of ImmunologyOpen Access

Fc receptor binding of anti‐CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine‐related side effects

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAnn C.T.M. VossenLeiden University Medical CenterGTG. John M. TibbeMKM.J. KroosErasmus University Rotterdam

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vossen et al. (1995) studied this question.

synapsesocial.com/papers/6ab5ea769f5e94797d863419https://doi.org/10.1002/eji.1830250603
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Technique of Free Skin Grafting in Mammals1951 · 751 citations
  2. 2A NON-ACTIVATING “HUMANIZED” ANTI-CD3 MONOCLONAL ANTIBODY RETAINS IMMUNOSUPPRESSIVE PROPERTIES IN VIVO1994 · 173 citations
  3. 3Identification of a monoclonal antibody specific for a murine T3 polypeptide.1987 · 1,617 citations
  4. 4The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.1984 · 118 citations
  5. 5Tyrosine-containing activation motif-dependent phagocytosis in mast cells.1994 · 52 citations